Thermo Fisher Scientific MSIA Steptavidin EVO Microcolumns

Thermo Fisher Scientific has launched the MSIA Streptavidin EVO microcolumns. The purification solution is designed to enable scientists to analyze large biomolecules. Housed in a pipette tip, the proprietary monolithic columns are densely coated with streptavidin for analytical affinity purification of any biotinylated affinity ligands, even at low concentration. Since the technology is incorporated into the pipette, users can analyze sample volumes as low as 10 μL, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.